Similarly, although both IRPs show increased expression in breast cancer cells compared to non-malignant mammary epithelial cells, TfR1 and FT levels were altered only by IRP2 knockdown, which led to decreased tumor growth in vivo. Here, IREB2 is linked to breast carcinoma.